Ausgabe 5/2020
Inhalt (28 Artikel)
Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis
Alexander J. Kovalic, Sanjaya K. Satapathy, Paul J. Thuluvath
Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis
Yanyan Wu, Hongyu Li, Xiaozhong Guo, Eric M. Yoshida, Nahum Mendez-Sanchez, Giovanni Battista Levi Sandri, Rolf Teschke, Fernando Gomes Romeiro, Akash Shukla, Xingshun Qi
Novel systemic therapy for hepatocellular carcinoma
Yawen Dong, Tsung-Hao Liu, Thomas Yau, Chiun Hsu
The role of neutrophils in innate immunity-driven nonalcoholic steatohepatitis: lessons learned and future promise
Lihong Wu, Xiang Gao, Qianyu Guo, Jufei Li, Jianyu Yao, Kaixuan Yan, Ying Xu, Xue Jiang, Dewei Ye, Jiao Guo
Interleukin-22 in alcoholic hepatitis and beyond
Xiaogang Xiang, Seonghwan Hwang, Dechun Feng, Vijay H. Shah, Bin Gao
Ileal bile acid transporter inhibition as an anticholestatic therapeutic target in biliary atresia and other cholestatic disorders
Saul J. Karpen, Deirdre Kelly, Cara Mack, Philip Stein
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
Shiv Kumar Sarin, Ashok Choudhury, George K. Lau, Ming-Hua Zheng, Dong Ji, Sherief Abd-Elsalam, Jaeseok Hwang, Xiaolong Qi, Ian Homer Cua, Jeong Ill Suh, Jun Gi Park, Opass Putcharoen, Apichat Kaewdech, Teerha Piratvisuth, Sombat Treeprasertsuk, Sooyoung Park, Salisa Wejnaruemarn, Diana A. Payawal, Oidov Baatarkhuu, Sang Hoon Ahn, Chang Dong Yeo, Uzziel Romar Alonzo, Tserendorj Chinbayar, Imelda M. Loho, Osamu Yokosuka, Wasim Jafri, Soeksiam Tan, Lau Ing Soo, Tawesak Tanwandee, Rino Gani, Lovkesh Anand, Eslam Saber Esmail, Mai Khalaf, Shahinul Alam, Chun-Yu Lin, Wan-Long Chuang, A. S. Soin, Hitendra K. Garg, Kemal Kalista, Badamnachin Batsukh, Hery Djagat Purnomo, Vijay Pal Dara, Pravin Rathi, Mamun Al Mahtab, Akash Shukla, Manoj K. Sharma, Masao Omata
Effect of COVID-19 on patients with compensated chronic liver diseases
Dong Ji, Dawei Zhang, Tieniu Yang, Jinsong Mu, Peng Zhao, Jing Xu, Chen Li, Gregory Cheng, Yudong Wang, Zhu Chen, Enqiang Qin, George Lau
Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis
Praveen Kumar-M, Shubhra Mishra, Daya Krishna Jha, Jayendra Shukla, Arup Choudhury, Ritin Mohindra, Harshal S. Mandavdhare, Usha Dutta, Vishal Sharma
Clinical characteristics and risk factors of liver injury in COVID-19: a retrospective cohort study from Wuhan, China
Ming Wang, Weiming Yan, Weipeng Qi, Di Wu, Lin Zhu, Weina Li, Xiaojing Wang, Ke Ma, Ming Ni, Dong Xu, Hongwu Wang, Guang Chen, Haijing Yu, Hongfang Ding, Mingyou Xing, Meifang Han, Xiaoping Luo, Tao Chen, Wei Guo, Dong Xi, Qin Ning
Liver injury in patients with COVID-19: clinical profiles, CT findings, the correlation of the severity with liver injury
Ping Lei, Lan Zhang, Ping Han, Chuansheng Zheng, Qiaoxia Tong, Haitao Shang, Fan Yang, Yu Hu, Xin Li, Yuhu Song
Hepatitis B virus infection and diabetes mellitus: the Kailuan prospective cohort study in China
Shaoyuan Lei, Shuohua Chen, Xinyu Zhao, Yanmin Zhang, Kailiang Cheng, Xiaohui Zhang, Zhenyu Wang, Yuanyuan Sun, Shouling Wu, Li Wang
Actual long-term survival in HCC patients with portal vein tumor thrombus after liver resection: a nationwide study
Zhen-Hua Chen, Xiu-Ping Zhang, Yu-Gang Lu, Le-Qun Li, Min-Shan Chen, Tian-Fu Wen, Wei-Dong Jia, Dong Zhou, Jing Li, Ding-Hua Yang, Zuo-Jun Zhen, Yi-Jun Xia, Rui-Fang Fan, Yang-Qing Huang, Yu Zhang, Xiao-Jing Wu, Yi-Ren Hu, Yu-Fu Tang, Jian-Hua Lin, Fan Zhang, Cheng-Qian Zhong, Wei-Xing Guo, Jie Shi, Joseph Lau, Shu-Qun Cheng
Clinical benefits of PD-1/PD-L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and meta-analysis
Quan Rao, Min Li, Wei Xu, Kai Pang, XiaoBo Guo, Dong Wang, Jun Liu, Wei Guo, ZhongTao Zhang
Lymphocyte to monocyte ratio-based nomogram for predicting outcomes of hepatocellular carcinoma treated with sorafenib
Yeonjung Ha, Mohamed A. Mohamed Ali, Molly M. Petersen, William S. Harmsen, Terry M. Therneau, Han Chu Lee, Baek-Yeol Ryoo, Sally Bampoh, Kenneth A. Valles, Mohamad Mady, Venkata R. Missula, Kritika Prasai, Lewis R. Roberts, Kang Mo Kim
Stereotactic body radiotherapy versus hepatic resection for hepatocellular carcinoma (≤ 5 cm): a propensity score analysis
Jing Sun, Quan Wang, Zhi-Xian Hong, Wen-Gang Li, Wei-Ping He, Tao Zhang, Ai-Min Zhang, Yu-Ze Fan, Ying-Zhe Sun, Li Zheng, Xue-Zhang Duan
Portal inflammation predicts renal dysfunction in patients with nonalcoholic fatty liver disease
Jung Nam An, Sae Kyung Joo, Bo Kyung Koo, Jung Ho Kim, Sohee Oh, Won Kim
Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease
Chao Cen, Wenpu Wang, Songfeng Yu, Xiaofeng Tang, Jimin Liu, Yuanxing Liu, Lin Zhou, Jun Yu, Shusen Zheng
Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study
Jorge Luis Poo, Aldo Torre, Juan Ramón Aguilar-Ramírez, Mauricio Cruz, Luis Mejía-Cuán, Eira Cerda, Alfredo Velázquez, Angélica Patiño, Carlos Ramírez-Castillo, Laura Cisneros, Francisco Bosques-Padilla, Larissa Hernández, Frida Gasca, Francisco Flores-Murrieta, Samuel Treviño, Graciela Tapia, Juan Armendariz-Borunda, Linda E. Muñoz-Espinosa
Silencing of functional p53 attenuates NAFLD by promoting HMGB1-related autophagy induction
Xuequn Zhang, Yiming Lin, Sisi Lin, Chunxiao Li, Jianguo Gao, Zemin Feng, Jinghua Wang, Jie Zhang, Hong Zhang, Yuwei Zhang, Xueyang Chen, Shenghui Chen, Chengfu Xu, Youming Li, Chaohui Yu, Hang Zeng
Maternal–fetal outcome in pregnancies complicated with non-cirrhotic portal hypertension: experience from a Tertiary Centre in South India
Anish Keepanasseril, Avantika Gupta, Devika Ramesh, Keerthana Kothandaraman, Yavana Suriya Jeganathan, Dilip Kumar Maurya
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients
Giovanni Marasco, Elton Dajti, Federico Ravaioli, Luigina Vanessa Alemanni, Fabiana Capuano, Kamela Gjini, Luigi Colecchia, Giovanni Puppini, Caterina Cusumano, Matteo Renzulli, Rita Golfieri, Davide Festi, Antonio Colecchia
Functionality of beta-adrenergic receptors in patients with cirrhosis treated chronically with non-selective beta-blockers
Susana Almenara, Beatriz Lozano, Paula Gimenez, Ivan Herrera, Cayetano Miralles, Pablo Bellot, María Rodríguez, Rubén Francés, Jose M. Gonzalez-Navajas, Sonia Pascual, Pedro Zapater
Effect of HBV-HDV co-infection on HBV-HCC co-recurrence in patients undergoing living donor liver transplantation
Adil Baskiran, Sami Akbulut, Tevfik Tolga Sahin, Cemalettin Koc, Serdar Karakas, Volkan Ince, Cihan Yurdaydin, Sezai Yilmaz
Liver injury in remdesivir-treated COVID-19 patients
Rosa Zampino, Ferruccio Mele, Letizia Lucia Florio, Lorenzo Bertolino, Roberto Andini, Maria Galdo, Rosanna De Rosa, Antonio Corcione, Emanuele Durante-Mangoni
Proposed mechanism for increased COVID-19 mortality in patients with decompensated cirrhosis
Josephine A. Grace, Stephen Casey, Louise M. Burrell, Peter W. Angus
Is tenofovir more effective than entecavir to prevent hepatocellular carcinoma? The controversy goes on
Cheng-Hao Tseng, Mindie H. Nguyen, Yao-Chun Hsu